Related Experiment Video

Updated: Jun 20, 2026

A Simple Protocol for Platelet-mediated Clumping of Plasmodium falciparum-infected Erythrocytes in a Resource Poor Setting
07:27

A Simple Protocol for Platelet-mediated Clumping of Plasmodium falciparum-infected Erythrocytes in a Resource Poor Setting

Published on: May 16, 2013

Immune thrombocytopenia in children with reference to low-income countries

A Rehman1

  • 1Bahawal Victoria Hospital, Bahawalpur, Pakistan. drarehman100@yahoo.com

Eastern Mediterranean Health Journal = La Revue De Sante De La Mediterranee Orientale = Al-Majallah Al-Sihhiyah Li-Sharq Al-Mutawassit
|September 8, 2009
PubMed

Insights

Immune thrombocytopenia (ITP) is generally mild and self-limiting. This review compares ITP in low- and high-income nations, finding similar remission rates and rare complications, supporting observation or oral steroids as economical treatments.

Area of Science:

  • Hematology
  • Pediatrics
  • Global Health

Background:

  • Immune thrombocytopenia (ITP) is a common bleeding disorder.
  • Limited data exists on ITP incidence and management in low-income countries.
  • Understanding global disparities in ITP is crucial for equitable healthcare.

Purpose of the Study:

  • To review and compare immune thrombocytopenia research between low- and high-income countries.
  • To assess diagnostic approaches and treatment outcomes globally.
  • To highlight the epidemiology and management of ITP in diverse economic settings.

Main Methods:

  • Systematic literature review of immune thrombocytopenia studies.
  • Comparative analysis of data from low-income versus high-income countries.
  • Evaluation of diagnostic criteria and treatment strategies.

Main Results:

  • Immune thrombocytopenia demonstrates high remission rates in both low- and high-income countries.
  • Intracranial hemorrhage is a rare complication globally.
  • Diagnosis relies on complete blood count, peripheral smear, and sometimes bone marrow aspiration.

Conclusions:

  • Immune thrombocytopenia is a benign, self-limiting condition worldwide.
  • Observation is recommended for most cases, especially with platelet counts above 10,000/mm³.
  • Oral steroids represent an economical treatment option when necessary.

More Related Videos

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis08:44

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis

Published on: September 7, 2022

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells09:46

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells

Published on: December 27, 2017

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...